Abstract:
Combined treatment with antiaggregants and anticoagulants may constitute a scheduling approach for the treatment of intense coronary disorder
without ST fragment height (AC-ST) in patients with a lack of iron deficiency. However, a few of these patients are at high risk of hemorrhagic
complications. This work highlights the importance of choosing the restorative procedure for such patients. The review examination of therapeutic
cards of 112 patients alluded to the Office of Cardiac Activity with Determination of AC-ST included the estimation of the adequacy and safety of
the anticoagulant heparin in the treatment of press insufficiency iron deficiency in terms of the recurrence of thrombotic and hemorrhagic
complications and a guess of the result compared with the patients given no anticoagulants. A total of 35 patients were included. Antithrombotic
treatment ought to be endorsed for such patients, taking into account the chance of thrombotic complications. The possibility of stall rot loss and
frailty in patients with CS-STs requires illustration and evaluation of hemorrhage risk variables (HAS-BLenn scale), the latter of which determine
the choice of modality for encouraging treatment.
